Literature DB >> 12754012

Aerosol flow reactor method for synthesis of drug nanoparticles.

Hannele Eerikäinen1, Wiwik Watanabe, Esko I Kauppinen, P Petri Ahonen.   

Abstract

An aerosol flow reactor method, a one-step continuous process to produce nanometer-sized drug particles with unimodal size distribution, was developed. This method involves first dissolving the drug material in question into a suitable solvent, which is then followed by atomising the solution as fine droplets into carrier gas. A heated laminar flow reactor tube is used to evaporate the solvent, and solid drug nanoparticles are formed. In this study, the effect of drying temperature on the particle size and morphology was examined. A glucocorticosteroid used for asthma therapy, beclomethasone dipropionate, was selected as an experimental model drug. The geometric number mean particle diameter increases significantly with increasing reactor temperatures due to formation of hollow nanoparticles. Above 160 degrees C, however, further increase in temperature results in decreasing particle size. The produced nanoparticles are spherical and show smooth surfaces at all studied experimental conditions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12754012     DOI: 10.1016/s0939-6411(03)00005-5

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  9 in total

Review 1.  Nanoparticles: pharmacological and toxicological significance.

Authors:  C Medina; M J Santos-Martinez; A Radomski; O I Corrigan; M W Radomski
Journal:  Br J Pharmacol       Date:  2007-01-22       Impact factor: 8.739

2.  What is a suitable dissolution method for drug nanoparticles?

Authors:  Desmond Heng; David J Cutler; Hak-Kim Chan; Jimmy Yun; Judy A Raper
Journal:  Pharm Res       Date:  2008-03-05       Impact factor: 4.200

3.  Aerosolization, Drug Permeation and Cellular Interaction of Dry Powder Pulmonary Formulations of Corticosteroids with Hydroxypropyl-β-Cyclodextrin as a Solubilizer.

Authors:  Ville Vartiainen; Luis M Bimbo; Jouni Hirvonen; Esko I Kauppinen; Janne Raula
Journal:  Pharm Res       Date:  2016-09-07       Impact factor: 4.200

4.  Intact nanoparticulate indomethacin in fast-dissolving carrier particles by combined wet milling and aerosol flow reactor methods.

Authors:  Timo Laaksonen; Peng Liu; Antti Rahikkala; Leena Peltonen; Esko I Kauppinen; Jouni Hirvonen; Kristiina Järvinen; Janne Raula
Journal:  Pharm Res       Date:  2011-05-04       Impact factor: 4.200

5.  A novel gas phase method for the combined synthesis and coating of pharmaceutical particles.

Authors:  Janne Raula; Anna Lähde; Esko I Kauppinen
Journal:  Pharm Res       Date:  2007-10-20       Impact factor: 4.200

6.  Investigations on the humidity-induced transformations of salbutamol sulphate particles coated with L-leucine.

Authors:  Janne Raula; Frank Thielmann; Jarno Kansikas; Sami Hietala; Minna Annala; Jukka Seppälä; Anna Lähde; Esko I Kauppinen
Journal:  Pharm Res       Date:  2008-06-27       Impact factor: 4.200

7.  Preparation and in-vitro evaluation of indomethacin nanoparticles.

Authors:  A Rezaei Mokarram; A Kebriaee Zadeh; M Keshavarz; A Ahmadi; B Mohtat
Journal:  Daru       Date:  2010       Impact factor: 3.117

Review 8.  Lignin from Micro- to Nanosize: Production Methods.

Authors:  Stefan Beisl; Angela Miltner; Anton Friedl
Journal:  Int J Mol Sci       Date:  2017-06-10       Impact factor: 5.923

Review 9.  Nanocrystals based pulmonary inhalation delivery system: advance and challenge.

Authors:  Pengfei Yue; Weicheng Zhou; Guiting Huang; Fangfang Lei; Yingchong Chen; Zhilin Ma; Liru Chen; Ming Yang
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.